Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assess the Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and Non-alcoholic Fatty Liver Disease

NCT05647915 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT05647915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05647915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assess the Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and Non-alcoholic Fatty Liver Disease
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Phase 4
Overall status
Completed
Start date
July 6, 2023
Completion date
August 9, 2024
Enrollment
337 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nafld, obesity, obesity, abdominal